Home
Final Stage Lung Cancer News
Bone Cancer Links
Sitemap

Navigation

Breast cancer type
Leading types of cancer
Breast cancer stages
Childhood cancer types
Bone cancer
Cancer research uk
Breast cancer sites
Types of skin cancer
Stomach cancer types symptoms
What causes cancer
Cancer symptoms
Brain cancer
Signs of breast cancer
Facts about lung cancer
Prostate cancer



Cancer Recommended Products


Lung Cancer Side Effects News

Lung cancer pill may get second chance after tests - Reuters


Lung cancer pill may get second chance after tests
Reuters - 7 hours ago
Chemotherapy, infused over a period of several hours, targets rapidly growing cells and thus often has severe side effects such as nausea, diarrhea and hair ...

Read more...


The Great American Smokeout Is Your Chance To Start A Healthy Life - eFluxMedia


eFluxMedia

The Great American Smokeout Is Your Chance To Start A Healthy Life
eFluxMedia - 13 hours ago
We shall also not forget that November is Lung Cancer Awareness Month, a month dedicated to raising awareness on the most devastating side effect of ...

Read more...


Cancer Drug Ups Risk of Clots in Veins - U.S. News & World Report


TheMedGuru

Cancer Drug Ups Risk of Clots in Veins
U.S. News & World Report, DC - Nov 18, 2008
This risk lengthens an already long list of severe side effects associated with the drug, including clots in the artery, heart attacks, stroke and bowel ...
Genentech disputes new Avastin research data San Francisco Chronicle
Avastin More Likely to Cause Blood Clots in Veins, Study Says Newsinferno.com
FDA 'black box' warning advised for cancer drug Avastin USA Today
Medical News Today (press release) - AboutLawsuits.com
all 64 news articles

Read more...


Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of ... - MarketWatch


dBTechno

Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of ...
MarketWatch - 23 hours ago
Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market. ...
Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of ... International Business Times
all 56 news articles

Read more...


Randomized Phase 2 Study of IMC-A12 for HER2-Expressing Advanced ... - MarketWatch


Randomized Phase 2 Study of IMC-A12 for HER2-Expressing Advanced ...
MarketWatch - Nov 19, 2008
NCCTG specializes in researching methods of treating and preventing cancer, and in researching methods to alleviate the side effects of cancer and cancer ...

Read more...